PPDTM CorEvitasTM Vitiligo Drug Safety and Effectiveness Registry for Adults & Adolescents
CorEvitas · NCT07659418
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 12+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 2500
- US sites recruiting
- 1
- Study start
- August 21, 2026
- Record last updated
- August 26, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The design is a prospective, observational (non-interventional) registry for adolescent and adult subjects with NSV under the care of a dermatology provider.
Conditions: Vitiligo
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Individuals are eligible for enrollment if they meet all of the following criteria:
- Have a dermatologist- or qualified dermatology practitioner-confirmed diagnosis of nonsegmental vitiligo (NSV).
- Is at least 12 years of age or older at the time of enrollment.
- Is willing and able to provide informed consent or assent, with parent/legal guardian consent as applicable.
- Adult participants are willing and able to provide required personal information
- Full legal name, sex, date of birth, and home ZIP/postal code
- Meet the criteria for one of the following enrollment cohorts at the time of enrollment:
Cohort 1: Eligible Medication Initiators - Individuals initiating a prescribed eligible NSV medication at the time of enrollment.
Cohort 2: Not Initiating Eligible Medication - Individuals not currently receiving NSV medication at the time of enrollment, Individuals receiving eligible NSV medication prior to enrollment.
Exclusion Criteria
An individual who meets any of the following criteria will be excluded from participation in the registry:
- Is participating or planning to participate in a blinded clinical trial for a vitiligo therapy.
Recruiting US locations
CorEvitas, LLC
Waltham, MA 02451
Site contact: CorEvitas Vitiligo Registry Team · 508-408-5531 · VITregistry@thermofisher.com
Study contacts (from the official record)
- Vitiligo Registry Study Team · 508-408-5531 · VITregistry@thermofisher.com
Similar studies in Massachusetts
All dermatology studies in Massachusetts →- RecruitingHealthy volunteers
AVAVA MIRIA General Use
AVAVA, Inc.
- Location
- Waltham, MA
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Oruka Therapeutics, Inc.
- Location
- Boston, MA + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Sanofi
- Location
- Boston, MA + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Bristol-Myers Squibb
- Location
- Brighton, MA + 90 other US sites
- Eligibility basics
- Ages 40+